International Stem Cell (ISCO) Preferred Shares (2010 - 2026)
International Stem Cell (ISCO) posted quarterly Preferred Shares of $5000.0 for Q4 2025, little changed year-over-year from $5000.0 in Q4 2024, and little changed quarter-over-quarter from $5000.0 in Q3 2025.
International Stem Cell (ISCO) Preferred Shares (2010 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported Preferred Shares for 16 consecutive years, with $5000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Preferred Shares changed 0.0% year-over-year to $5000.0; the TTM figure through Dec 2025 stood at $5000.0 (changed 0.0% YoY), while the FY2025 annual figure was $5000.0, changed 0.0% from the prior year.
- Preferred Shares steadied at $5000.0 in Q4 2025 per ISCO's latest filing, from $5000.0 in the prior quarter.
- Across five years, Preferred Shares topped out at $5000.0 in Q1 2021 and bottomed at $5000.0 in Q1 2021.
- Historically, Preferred Shares has averaged $5000.0 across 5 years, with a median of $5000.0 in 2021.
- On a YoY basis, Preferred Shares climbed as much as 0.0% in 2021 and fell as far as 0.0% in 2021.
- International Stem Cell's Preferred Shares stood at $5000.0 in 2021, then changed by 0.0% to $5000.0 in 2022, then changed by 0.0% to $5000.0 in 2023, then changed by 0.0% to $5000.0 in 2024, then changed by 0.0% to $5000.0 in 2025.
- Business Quant data shows ISCO's Preferred Shares at $5000.0 in Q4 2025, $5000.0 in Q3 2025, and $5000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | International Stem Cell | 4.32 Mn | 3.23 Mn | 1.46 Mn | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | 5,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 5,000.00 |